NASDAQ Biotechnology Total Retu XNBI Índice
4429.24 USD
{{ price }}
-0.882975%
{{change_pct}}%
País
Estados Unidos
Intercambiar
Nasdaq GIDS
Baja - Alta [24h]
4424.12
-
4478.71 USD
Número de componentes
190
NASDAQ Biotechnology Total Retu Gráfico de precios
Principales 5 Ganadores en las Últimas 24 Horas
| PACB | Pacific Biosciences of California | +20.85% | |
|---|---|---|---|
| TRVN | Trevena | +14% | |
| OCUL | Ocular Therapeutix | +13.69% | |
| MYGN | Myriad Genetics | +4.58% | |
| ATRA | Atara Biotherapeutics | +4.07% |
Principales 5 Perdedores en las Últimas 24 Horas
| EGRX | Eagle Pharmaceuticals | -17.5% | |
|---|---|---|---|
| NVAX | Novavax | -5.92% | |
| CLDX | Celldex Therapeutics | -5.66% | |
| IRWD | Ironwood Pharmaceuticals | -4.85% | |
| BPMC | Blueprint Medicines | -4.76% |
RESUMEN FINANCIERO Y BURSÁTIL DE NASDAQ Biotechnology Total Retu XNBI
| NASDAQ Biotechnology Total Retu Precio del Índice | 4429.24 USD |
| Cierre anterior | 4472.96 USD |
| Abrir | 4476.26 USD |
| Oferta | 0 USD x 0 |
| Precio de compra | 0 USD x 0 |
| Rango diario | 4464.53 - 4532.84 USD |
| Intervalo de 52 semanas | 4464.53 - 4532.84 USD |
| Volumen | 0 USD |
| Media Volumen | N/A |
Información de operaciones
NASDAQ Biotechnology Total Retu Historial de precios del índice
| Máximo de 52 semanas | 4532.84 USD |
| Mínimo de 52 semanas | 4464.53 USD |
| Media móvil de 50 sesiones | N/A |
| Media móvil de 200 sesiones | N/A |
XNBI Estadísticas del índice
| Vol medio (3 meses) | N/A |
| Vol medio (10 días) | N/A |
Preguntas y respuestas sobre el Índice NASDAQ Biotechnology Total Retu
¿Cuál es el precio actual del Índice XNBI?
El precio del Índice NASDAQ Biotechnology Total Retu XNBI hoy es de 4429.24 USD.
¿Cómo comprar el Índice NASDAQ Biotechnology Total Retu?
Puede comprar el índice XNBI en la bolsa de valores Nasdaq GIDS. Consulte a su asesor financiero para seleccionar un bróker.
¿Cuál es el símbolo bursátil del Índice NASDAQ Biotechnology Total Retu?
El símbolo o código bursátil del Índice NASDAQ Biotechnology Total Retu es XNBI.
¿Cuántos componentes contiene el Índice NASDAQ Biotechnology Total Retu?
El índice NASDAQ Biotechnology Total Retu contiene 190 componentes.
¿A qué país pertenece el Índice NASDAQ Biotechnology Total Retu?
El índice NASDAQ Biotechnology Total Retu pertenece a United States.
¿En qué bolsa se encuentra listado el Índice NASDAQ Biotechnology Total Retu?
El índice NASDAQ Biotechnology Total Retu está listado en la bolsa de valores Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPONENTES
| Nombre Nombre | Precio Precio |
24h% 7d chart 24h% 7d chart |
Cap.mercado Сap. del mercado | Vol. Volumen | bajo en 24h | alto en 24h | Сap. del mercado | PER | BPA |
|---|
| Nombre Nombre | Precio Precio |
24h% 7d chart 24h% 7d chart |
Cap.mercado Сap. del mercado | Vol. Volumen | bajo en 24h | alto en 24h | Сap. del mercado | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $278.4 — |
-0.38
|
$149.7B — | $3.75M — | $276.62 — | $281.34 — | $149.7B — | 25.35 | $10.98 — |
| Gilead Sciences GILD | $108.3 — |
-0.72
|
$134.72B — | $2.92M — | $107.23 — | $109.45 — | $134.72B — | 22.75 | $4.76 — |
| Vertex Pharmaceuticals Incorporated VRTX | $445.1 — |
-0.2
|
$114.3B — | $1.18M — | $443.41 — | $451.64 — | $114.3B — | 0 | -$3.84 — |
| Regeneron Pharmaceuticals REGN | $591.85 — |
-1.89
|
$63.9B — | $1M — | $590.25 — | $605.97 — | $63.9B — | 15.04 | $39.33 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $285.56 — |
-1.56
|
$37.23B — | $877.87K — | $285.55 — | $291.54 — | $37.23B — | 0 | -$2.09 — |
| Biogen BIIB | $127.53 — |
-0.67
|
$18.69B — | $1.5M — | $126.87 — | $129.86 — | $18.69B — | 12.60 | $10.12 — |
| United Therapeutics UTHR | $316.04 — |
+0.38
|
$14.26B — | $275.87K — | $315.21 — | $319.09 — | $14.26B — | 12.59 | $25.09 — |
| Illumina ILMN | $84.43 — |
+2.35
|
$13.37B — | $2.35M — | $82.1 — | $85.06 — | $13.37B — | 0 | -$6.08 — |
| Incyte INCY | $65.08 — |
-0.41
|
$12.6B — | $750.76K — | $64.85 — | $65.6 — | $12.6B — | 325.39 | $0.2 — |
| Neurocrine Biosciences NBIX | $123.03 — |
+0.32
|
$12.18B — | $1.02M — | $122.47 — | $124.3 — | $12.18B — | 41.56 | $2.96 — |
| Insmed Incorporated INSM | $66.36 — |
-2.44
|
$12.09B — | $2.01M — | $66.08 — | $68.27 — | $12.09B — | 0 | -$5.93 — |
| Exelixis EXEL | $42.41 — |
-1.58
|
$11.57B — | $2.7M — | $42.39 — | $43.75 — | $11.57B — | 19.36 | $2.19 — |
| BioMarin Pharmaceutical BMRN | $57.87 — |
-0.41
|
$11.1B — | $1.25M — | $57.79 — | $59.12 — | $11.1B — | 21.43 | $2.7 — |
| Qiagen QGEN | $44.38 — |
+1.21
|
$9.61B — | $1.39M — | $43.99 — | $44.5 — | $9.61B — | 103.20 | $0.43 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Bio-Techne TECH | $47.93 — |
-1.56
|
$7.51B — | $2.61M — | $47.25 — | $48.84 — | $7.51B — | 57.74 | $0.83 — |
| Repligen RGEN | $121.18 — |
-1.11
|
$6.81B — | $515.45K — | $120.55 — | $123.13 — | $6.81B — | 0 | -$0.42 — |
| Grifols, S.A. GRFS | $8.28 — |
+0.55
|
$6.76B — | $331.96K — | $8.24 — | $8.34 — | $6.76B — | 31.82 | $0.26 — |
| Halozyme Therapeutics HALO | $54.43 — |
+0.02
|
$6.71B — | $1.79M — | $54.22 — | $55.09 — | $6.71B — | 14.47 | $3.76 — |
- {{ link.label }} {{link}}